<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We had reported that N-myc downstream-regulated gene (NDRG2) regulates <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, <z:hpo ids='HP_0003002'>breast cancer</z:hpo>, <z:hpo ids='HP_0006770'>clear cell renal cell carcinoma</z:hpo>, <z:hpo ids='HP_0002894'>pancreatic cancer</z:hpo>, <z:e sem="disease" ids="C0007115" disease_type="Neoplastic Process" abbrv="">thyroid cancer</z:e> and esophageal squamous cell proliferation, development, and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="1" pm="."><plain>The goal of this study was to determine the expression pattern of NDRG2 in human <z:e sem="disease" ids="C0242379" disease_type="Neoplastic Process" abbrv="">lung cancer</z:e> and its correlation with prognosis </plain></SENT>
<SENT sid="2" pm="."><plain>Immunohistochemistry, RT-PCR and western blot were used to explore the expression of NDRG2 in 185 human <z:e sem="disease" ids="C0242379" disease_type="Neoplastic Process" abbrv="">lung cancer</z:e> patients </plain></SENT>
<SENT sid="3" pm="."><plain>The correlation of NDRG2 expression with patients' survival rate was assessed by Kaplan-Meier and Cox regression </plain></SENT>
<SENT sid="4" pm="."><plain>Results showed that the expression level of NDRG2 was decreased in human <z:e sem="disease" ids="C0242379" disease_type="Neoplastic Process" abbrv="">lung cancer</z:e> tissues, and NDRG2 was positively correlated with depth of invasion (P = 0.038), vascular invasion (P = 0.036), <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> grade (P = 0.039), and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> size (P = 0.026) </plain></SENT>
<SENT sid="5" pm="."><plain>Both RT-PCR and Western blots demonstrated that NDRG2 <z:chebi fb="2" ids="33699">mRNA</z:chebi> and protein levels were lower in <z:e sem="disease" ids="C0242379" disease_type="Neoplastic Process" abbrv="">lung cancer</z:e> compared to the adjacent <z:mpath ids='MPATH_458'>normal</z:mpath> tissue from the same individual, and NDRG2 level was negatively correlated with UICC stage </plain></SENT>
<SENT sid="6" pm="."><plain>Additionally, survival time of <z:e sem="disease" ids="C0242379" disease_type="Neoplastic Process" abbrv="">lung cancer</z:e> patients with high expression of NDRG2 was longer than those with low expression during the 5-year follow-up period (P = 0.001) </plain></SENT>
<SENT sid="7" pm="."><plain>Meanwhile, COX regression analysis indicated that low expression of NDRG2, ≥pT(3), pM(1), ≥pN(1) and vascular invasion were independent, poor prognostic factors of <z:e sem="disease" ids="C0242379" disease_type="Neoplastic Process" abbrv="">lung cancer</z:e> patients </plain></SENT>
<SENT sid="8" pm="."><plain>These data showed that NDRG2 may play an important role in human <z:e sem="disease" ids="C0242379" disease_type="Neoplastic Process" abbrv="">lung cancer</z:e> <z:e sem="disease" ids="C1326912" disease_type="Neoplastic Process" abbrv="">tumourigenesis</z:e>, and NDRG2 might serve as a novel prognostic marker in human <z:e sem="disease" ids="C0242379" disease_type="Neoplastic Process" abbrv="">lung cancer</z:e> </plain></SENT>
</text></document>